-

Introducing The VEAZY: STORZ & BICKEL’s Most Compact and Accessible Vaporizer

Sleek portability. Precision engineering. Premium performance. Four exciting new colors

TUTTLINGEN, Germany--(BUSINESS WIRE)--STORZ & BICKEL GmbH (“STORZ & BICKEL” or the “Company”), a world-leading manufacturer of high-end, medically certified cannabis vaporizers and a subsidiary of Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC), today unveiled the VEAZY— an accessible new addition to its premium portfolio, extending the Company’s precision engineering to a broader audience.

The VEAZY delivers an uncompromising solution, designed to be as approachable as it is easy to use. The VEAZY is the first vaporizer from STORZ & BICKEL to be available in multiple colors that blend style with function—Charming Pink, Inspiring Orange, Dynamic Blue and Alluring Black.

VEAZY Key Features:

  • Compact Precision – At just 0.3lbs, it’s the smallest device in the portfolio, built for portability without compromise.
  • Customizable Style – Four distinct colorways make it the brands most vibrant and personal device yet.
  • Premium Vaporizer Quality – A patented mini heater, combining conduction and convection, delivers consistently dense, flavorful vapor.
  • Effortless Usability – With one-button control, three pre-set temperatures, and rapid ~40-second heat-up, VEAZY is simple for beginners and reliable for experts.
  • Accessible Value – With a $249 USD price point, the VEAZY makes STORZ & BICKEL’s world-class engineering more attainable than ever.
  • Worldwide Availability – The VEAZY will be available for purchase online and in-store at select retailers in upwards of 100 countries worldwide.
  • Bluetooth Compatible – The VEAZY connects via Bluetooth to the STORZ & BICKEL web app, allowing users to fine-tune settings and personalize sessions directly from their phone or laptop.
  • Fast Charging – A USB-C charging system powers the device to 80% in just 40 minutes.

“Consumers have been asking for a vaporizer that combines accessibility with style,” said Jürgen Bickel, Managing Director & Co-Founder, STORZ & BICKEL. “With the VEAZY, we’re expanding the STORZ & BICKEL experience to a new audience while staying true to the superior standards that have defined us for over 25 years.”

The VEAZY is available online at storz-bickel.com and at select licensed retailers worldwide.

To stay up-to-date on the latest product news, follow @storz.bickel on Instagram.

About STORZ & BICKEL GmbH

STORZ & BICKEL GmbH is the global leader in the manufacture of high-end and medically certified cannabis vaporizers. With a commitment to quality, innovation, and compliance, the company has consistently delivered exceptional products that meet the highest industry standards. Based in Tuttlingen, Germany, STORZ & BICKEL continues to drive the advancement of vaporization technology, providing a safe and efficient means of consuming cannabis for medical purposes. For more information, visit www.storz-bickel.com

About Canopy Growth

Canopy Growth is a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives. Through an unwavering commitment to consumers, Canopy Growth delivers innovative products from owned and licensed brands including Tweed, 7ACRES, DOJA, Deep Space, and Claybourne, as well as category defining vaporization devices by Storz & Bickel. In addition, Canopy Growth serves medical cannabis patients globally with principal operations in Canada, Europe and Australia.

Canopy Growth has also established a comprehensive ecosystem to realize the opportunities presented by the U.S. THC market through an unconsolidated, non-controlling interest in Canopy USA, LLC (“Canopy USA”). Canopy USA’s portfolio includes ownership of Acreage Holdings, Inc., a vertically integrated multi‑state cannabis operator with operations throughout the U.S. Northeast and Midwest, as well as ownership of Wana Wellness, LLC, The Cima Group, LLC, and Mountain High Products, LLC, a leading North American edibles brand, and majority ownership of Lemurian, Inc., a California-based producer of high-quality cannabis extracts and clean vape technology.

At Canopy Growth, we’re shaping a future where cannabis is embraced for its potential to enhance well-being and improve lives. With high-quality products, a commitment to responsible use, and a focus on enhancing the communities where we live and work, we’re paving the way for a better understanding of all that cannabis can offer. For more information, visit www.canopygrowth.com.

Contacts

Media Contacts:

Vatra Krasniqi, STORZ & BICKEL
Head of Marketing and Communications
Vatra.krasniqi@storz-bickel.com

Vanessa Jenkins, Canopy Growth
Communications
media@canopygrowth.com

STORZ & BICKEL GmbH

TSX:WEED

Release Versions

Contacts

Media Contacts:

Vatra Krasniqi, STORZ & BICKEL
Head of Marketing and Communications
Vatra.krasniqi@storz-bickel.com

Vanessa Jenkins, Canopy Growth
Communications
media@canopygrowth.com

More News From STORZ & BICKEL GmbH

Canopy Growth Launches Claybourne Gassers Liquid Diamonds All-In-One Vapes in Canada, Expanding Footprint in High-Growth Vape Segment

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, today announced the national launch of Claybourne Gassers, a new lineup of All-in-One (AIO) vapes featuring liquid diamonds. The launch marks Claybourne’s entry into Canada’s vape category, building on its leadership in high potency infused products. The Claybourne Gassers...

Canopy Growth Expands Spectrum Therapeutics Portfolio in Australia with New Softgels

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has expanded its Spectrum Therapeutics portfolio in Australia with the availability of new softgel capsules, further enhancing the Company’s medical cannabis offerings in the region. The formats include Spectrum Yellow Cannabis Oil Softgels (CBD 20mg), Spectrum Red Cannabis...

Canopy Growth Reports Second Quarter Fiscal 2026 Financial Results; Company Continues to Strengthen Financial Performance with Improving Adjusted EBITDA, Disciplined Cost Management, and a Stronger Balance Sheet

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED) (Nasdaq: CGC) today announced its financial results for the second quarter ended September 30, 2025 ("Q2 FY2026"). All financial information in this press release is reported in Canadian dollars, unless otherwise indicated. “We’re building a stronger, more competitive company defined by continued momentum in Canada adult-use cannabis, consistent growth in Canada medical cannabis, and...
Back to Newsroom